Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) are the first choice for the treatment of acute myocardial infarction (AMI), and angiotensin receptor blockers (ARBs) should be considered in patients intolerant to ACEIs. Although previous studies support the use of ARBs as an alternative...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Korean Med Sci
Autors principals: Lim, Sungmin, Choo, Eun Ho, Choi, Ik Jun, Ihm, Sang-Hyun, Kim, Hee-Yeol, Ahn, Youngkeun, Chang, Kiyuk, Jeong, Myung Ho, Seung, Ki-Bae
Format: Artigo
Idioma:Inglês
Publicat: The Korean Academy of Medical Sciences 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6875434/
https://ncbi.nlm.nih.gov/pubmed/31760711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2019.34.e289
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars